Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Orthop. Feb 18, 2026; 17(2): 112757
Published online Feb 18, 2026. doi: 10.5312/wjo.v17.i2.112757

Table 1 Medical comorbidities in the prosthetic joint infection cases

Citation: Nageeb Mahmoud AM, Maniar HH, Bernate J, Horwitz DS. Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. World J Orthop 2026; 17(2): 112757
URL: https://www.wjgnet.com/2218-5836/full/v17/i2/112757.htm
DOI: https://dx.doi.org/10.5312/wjo.v17.i2.112757

Nageeb Mahmoud AM, Maniar HH, Bernate J, Horwitz DS. Weight-adjusted low molecular weight heparin with surgery morning dose administration: Impact on hip hemiarthroplasty early infections. World J Orthop 2026; 17(2): 112757 [PMID: 41695736 DOI: 10.5312/wjo.v17.i2.112757]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.